May 29, 2012 | last updated May 29, 2012 10:51 am

Boston Scientific Product Clears FDA Hurdle

Natick-based Boston Scientific said the U.S. Food and Drug Administration has approved expanded use of a product that can remove difficult stones in a patient's common bile duct.

The action by the FDA, called an "indication," allows doctors to perform a stone-removal procedure with the product, called the CRE Wireguided Balloon Dilator. The procedure is called dilation assisted stone extraction, or DASE. The dilator "provides a new and alternative endoscopic therapy for more than 60-million people worldwide (who are) affected by the presence of stones in the common bile duct," said David Pierce, president of Boston Scientific's endoscopy division.


Type your comment here:

Today's Poll Has Worcester found the right solution for downtown with the CitySquare project?<>
Most Popular on Facebook
Copyright 2017 New England Business Media